INTRODUCTION 49
Exposure of humans to Mycobacterium tuberculosis, the cause of tuberculosis, induces a 50 highly variable response. Among persons exposed to M. tuberculosis, only 30-50% 51 become infected during an outbreak, and of those infected only approximately 10% 52 develop clinical disease. There is now clear evidence for the important impact of host 53 genetic factors on this variable response (3, 11, 12) . Evidence for an equally important 54 role of M. tuberculosis strain variability is emerging (reviewed in 18, 35) . A univariate 55 view would suggest that those who develop disease either display low resistance to 56 M. tuberculosis or are infected with high virulence strains of M. tuberculosis. An 57 alternate multivariate view is that M. tuberculosis and its human hosts have co-evolved 58 such that host susceptibility and pathogen virulence might better be considered in 59 combination. A specific M. tuberculosis isolate may cause disease in certain hosts but 60 not in others while a specific host may be susceptible to certain M. tuberculosis isolates 61 but resistant to others. The extent to which multivariate interactions are decisive for 62 tuberculosis susceptibility has far reaching consequences for tuberculosis control efforts 63 including vaccine development. Although studies have examined the impact of host 64 background and mycobacterial type separately, strategies that focus on the simultaneous7 NM). At one day post-infection, infectious doses of ~2 × 10 3 were confirmed by 141 homogenizing lungs in 2 ml of 0.025% Saponin-PBS using large tissue grinders (TYCO 142 where warranted, and p-values were adjusted for multiple testing with the simulation-200 based adjustment for multiple testing implemented in the SAS %SimTests macro (52) to 201 ensure an overall family-wise error rate (fwer). Also, for each bacterial strain separately, 202
we performed a two-way ANOVA to investigate differences in bacterial replication 203 across mouse strain and time. 3 ) and phenotypic traits of infection were measured at 1, 3, and 6 228 weeks, which are time points classically used to decipher susceptibility to BCG infection. 229
Since the ability of mycobacteria to replicate in the lungs is a critical predictor of 230 morbidity and mortality, pulmonary bacterial loads were compared in mice of both 231 strains by three-way ANOVA. This type of analysis partitions phenotypic variation into 232 host-, pathogen-, and time-related effects. Importantly, it provides a measure of host- shown to be the largest during M. tuberculosis infection, while BCG Russia had a lagged 321 expression for most of the genes tested. Expression differences across the three 322 mycobacteria were more pronounced in the A/J mouse strain. Among the genes that 323 were significantly up-or down-regulated, 15 and 11 genes were differentially expressed 324 across bacteria at 3 and 6 weeks, respectively (Tables 1 and 2 and Supplemental Tables 1  325 and 2). In C57BL6/J mice, differences in induction related to the mycobacteria were 326 observed for 9 genes at 3 weeks and for 3 genes at 6 weeks (Tables 1 and 2 and  327   Supplemental Tables 3 and 4 has been linked to a number of loci (24, 27, 39, 40, 46, 47, 53) . Taken responsiveness. Yet, even in our study with a dominant impact of the mycobacterial 367 pathogen on the studied phenotypes, it became clear that a comparison of the 368 mycobacteria for both pulmonary CFU burden and mechanistic phenotypes (Ifng and 369 chemokine transcript levels) had more discriminatory power in A/J mice as compared to 370 C57BL/6J mice. This highlights problems that can be encountered when studies 371 employing the same mycobacterial strain are compared in different hosts. Above all, the 372 analysis of common host responses to mycobacteria in this model system provided proof-373 of-principle for host-pathogen joint effects on phenotype variance. This is an important 374 extension of our previous observation of BCG strain-specific genetic control of BCGnecessity invokes differences in the pathogenesis, either quantitative or qualitative, 379 between different host-pathogen strain combinations. Given that both lung CFU and the 380 wide array of mechanistic phenotypes studied showed evidence for significant joint 381 mycobacteria-host effects, it seems likely that similar effects are also seen in human 382 Ccl, chemokine (C-C motif) ligand; Ccr, chemokine (C-C motif) receptor; Cx3cl1, 646 chemokine (C-X3-C motif) ligand 1; Cxcl, chemokine (C-X-C motif) ligand; Cxcr, 647 chemokine (C-X-C motif) receptor; Tnf, tumor necrosis factor; Il18, interleukin 18. 648 
